布里拉西丁是一种新型抗真菌剂,用于对抗Cryptococcus neoformans
Camila Diehl1, Camila Figueiredo Pinzan1, Patrícia Alves de Castro1
1Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, Brazil.
mBio
|June 25, 2024
概括
布里拉西丁 (BRI) 是一种新型抗真菌药物,可以对抗Cryptococcus neoformans,有效降低真菌生存率和肺部感染. 它还增强了现有的抗真菌药物,如菌素 (CAS).
科学领域:
- 菌类学和传染病的研究
- 药理学和药物发现
背景情况:
- 加密球菌病是一种由Cryptococcus neoformans引起的流行性真菌病,具有有限的治疗选择,构成了重大的全球健康挑战.
- 侵袭性真菌感染导致高死亡率,这凸显了对新型抗真菌剂的迫切需要.
研究的目的:
- 评估Brilacidin (BRI),一个模仿宿主防御,作为一种潜在的抗真菌剂,对抗Cryptococcus neoformans.
- 研究BRI单独或与现有的抗真菌药物结合,对C. neoformans的作用机制.
主要方法:
- 评估了BRI对C. neoformans的抗真菌活性及其对细胞膜透性的影响.
- 利用Saccharomyces cerevisiae突变库来探索BRI的细胞目标.
- 在入侵性肺结核病的小鼠模型中进行了体内研究,并评估了BRI与卡斯波金 (CAS) 的协同效应.
主要成果:
- BRI对C. neoformans表现出杀菌活性,影响细胞膜组织并增加透性.
- 在体内实验表明,BRI显著降低了巨细胞中的C. neoformans存活率,并部分清除了肺部感染.
- BRI增强了CAS的抗真菌活性,影响了真菌内细胞运动,氨酸和MAPK通路.
结论:
- 布里拉西丁 (BRI) 是一种有前途的新型抗真菌药物候选药物,用于治疗加密球菌病.
- BRI表现出多方面的作用机制,向真菌细胞膜并增强现有的疗法.
相关概念视频
Drugs for Treatment of Diarrhea-Predominant IBS
1.0K
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
1.0K
Drugs for Treatment of Ulcerative Colitis in IBD
721
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
721
Differential Staining Technique
2.7K
Differential staining is an essential microbiological technique that exploits variations in cell wall structures to classify and identify microorganisms. It facilitates the distinction of bacteria, aiding in diagnostic and research applications. Two of the most widely used differential staining methods are Gram staining and acid-fast staining, both of which rely on the chemical and structural differences in bacterial cell walls.Gram Staining TechniqueGram staining differentiates bacteria by...
2.7K
Inhibitors of Bacterial DNA Synthesis
163
Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These...
163
Antifungal Agents
132
Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to...
132
Clinical Significance of Antibiotic Resistance
115
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
115


